The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

PURPOSE: By applying the principles of real-time biopsy, biomarker-based, adaptively randomized studies in non–small-cell lung cancer (NSCLC) established by the Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial, we conducted BATTLE-2 (BATTLE-2 Program: A...

詳細記述

保存先:
書誌詳細
出版年:J Clin Oncol
主要な著者: Papadimitrakopoulou, Vassiliki, Lee, J. Jack, Wistuba, Ignacio I., Tsao, Anne S., Fossella, Frank V., Kalhor, Neda, Gupta, Sanjay, Byers, Lauren Averett, Izzo, Julie G., Gettinger, Scott N., Goldberg, Sarah B., Tang, Ximing, Miller, Vincent A., Skoulidis, Ferdinandos, Gibbons, Don L., Shen, Li, Wei, Caimiao, Diao, Lixia, Peng, S. Andrew, Wang, Jing, Tam, Alda L., Coombes, Kevin R., Koo, Ja Seok, Mauro, David J., Rubin, Eric H., Heymach, John V., Hong, Waun Ki, Herbst, Roy S.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2016
主題:
ORIGINAL REPORTS
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065110/
https://ncbi.nlm.nih.gov/pubmed/27480147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.66.0084
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料